These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 15693113

  • 1. B cell-targeted therapy in diseases other than rheumatoid arthritis.
    Looney RJ.
    J Rheumatol Suppl; 2005 Feb; 73():25-8; discussion 29-30. PubMed ID: 15693113
    [Abstract] [Full Text] [Related]

  • 2. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [Abstract] [Full Text] [Related]

  • 3. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [Abstract] [Full Text] [Related]

  • 4. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S, Akashi T, Katsuta H, Iwakiri R, Anzai K, Nagafuchi S, Niho Y, Harada M.
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. B cell targeted therapies in autoimmune diseases.
    Isenberg DA.
    J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy.
    Silverman GJ, Weisman S.
    Arthritis Rheum; 2003 Jun; 48(6):1484-92. PubMed ID: 12794814
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.
    Kazkaz H, Isenberg D.
    Curr Opin Pharmacol; 2004 Aug; 4(4):398-402. PubMed ID: 15251135
    [Abstract] [Full Text] [Related]

  • 12. Use of rituximab in patients with systemic lupus erythematosus: an update.
    García-Carrasco M, Jiménez-Hernández M, Escárcega RO, Mendoza-Pinto C, Galarza-Maldonado C, Sandoval-Cruz M, Zamudio-Huerta L, López-Colombo A, Cervera R.
    Autoimmun Rev; 2009 Feb; 8(4):343-8. PubMed ID: 19036350
    [Abstract] [Full Text] [Related]

  • 13. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R.
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [Abstract] [Full Text] [Related]

  • 14. Rituximab in autoimmune diseases.
    Virgolini L, Marzocchi V.
    Biomed Pharmacother; 2004 Jun; 58(5):299-309. PubMed ID: 15194166
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rituximab use in pediatric autoimmune diseases: four case reports.
    Polido-Pereira J, Ferreira D, Rodrigues AM, Nascimento C, Costa P, Almeida M, da Silva JE, Simão C, Stone R, Ramos F, Neto A, da Costa JC, Melo-Gomes J, Gomes-Pedro J, Viana-Queiroz M, Canhão H, Fonseca JE.
    Ann N Y Acad Sci; 2009 Sep; 1173():712-20. PubMed ID: 19758220
    [Abstract] [Full Text] [Related]

  • 17. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG, Jones RB, Burns SM, Jayne DR.
    Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
    [Abstract] [Full Text] [Related]

  • 18. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
    Levesque MC, St Clair EW.
    J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502
    [Abstract] [Full Text] [Related]

  • 19. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R, Albert D.
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [Abstract] [Full Text] [Related]

  • 20. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
    Mantadakis E, Danilatou V, Stiakaki E, Kalmanti M.
    Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.